Novel tripeptides with α-glucosidase inhibitory activity isolated from silk cocoon hydrolysate. 2011

Hyun Jung Lee, and Hyun-Sun Lee, and Jang Won Choi, and Kyung Soo Ra, and Jin-Man Kim, and Hyung Joo Suh
Department of Food and Nutrition, Korea University, Seoul 130-701, Republic of Korea.

Active compounds with antidiabetic potential were isolated from silk peptide E5K6 by consecutive ultrafiltration and gel filtration using Biogel P-2 and RS-HPLC using a YMC-Pack Pro C18 column. The highest α-glucosidase inhibitory activity of silk peptide E5K6 resulted from fractions with MW <1 kDa. The activities of gel-filtered fractions from silk peptide E5K6 of <1 kDa were assayed in vitro, demonstrating that the fourth peak (F4) had the highest α-glucosidase inhibitory activity (IC(50) = 37.1 mg/mL). F4 of silk peptide E5K6 was separated by HPLC into two peaks. Moreover, the purified compounds were identified as Gly-Glu-Tyr (GEY, MW = 367 Da) and Gly-Tyr-Gly (GYG, MW = 295 Da) according to amino acid sequences, and their α-glucosidase inhibitory activities (IC(50)) were 2.7 and 1.5 mg/mL, respectively.

UI MeSH Term Description Entries
D007004 Hypoglycemic Agents Substances which lower blood glucose levels. Antidiabetic,Antidiabetic Agent,Antidiabetic Drug,Antidiabetics,Antihyperglycemic,Antihyperglycemic Agent,Hypoglycemic,Hypoglycemic Agent,Hypoglycemic Drug,Antidiabetic Agents,Antidiabetic Drugs,Antihyperglycemic Agents,Antihyperglycemics,Hypoglycemic Drugs,Hypoglycemic Effect,Hypoglycemic Effects,Hypoglycemics,Agent, Antidiabetic,Agent, Antihyperglycemic,Agent, Hypoglycemic,Agents, Antidiabetic,Agents, Antihyperglycemic,Agents, Hypoglycemic,Drug, Antidiabetic,Drug, Hypoglycemic,Drugs, Antidiabetic,Drugs, Hypoglycemic,Effect, Hypoglycemic,Effects, Hypoglycemic
D009842 Oligopeptides Peptides composed of between two and twelve amino acids. Oligopeptide
D004791 Enzyme Inhibitors Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction. Enzyme Inhibitor,Inhibitor, Enzyme,Inhibitors, Enzyme
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D006868 Hydrolysis The process of cleaving a chemical compound by the addition of a molecule of water.
D000520 alpha-Glucosidases Enzymes that catalyze the exohydrolysis of 1,4-alpha-glucosidic linkages with release of alpha-glucose. Deficiency of alpha-1,4-glucosidase may cause GLYCOGEN STORAGE DISEASE TYPE II. Acid Maltase,Lysosomal alpha-Glucosidase,Maltase,Maltases,Maltase-Glucoamylase,Neutral Maltase,Neutral alpha-Glucosidase,alpha-Glucosidase,Lysosomal alpha Glucosidase,Maltase Glucoamylase,Neutral alpha Glucosidase,alpha Glucosidase,alpha Glucosidases,alpha-Glucosidase, Lysosomal,alpha-Glucosidase, Neutral
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D012831 Bombyx A genus of silkworm MOTHS in the family Bombycidae of the order LEPIDOPTERA. The family contains a single species, Bombyx mori from the Greek for silkworm + mulberry tree (on which it feeds). A native of Asia, it is sometimes reared in this country. It has long been raised for its SILK and after centuries of domestication it probably does not exist in nature. It is used extensively in experimental GENETICS. (From Borror et al., An Introduction to the Study of Insects, 4th ed, p519) Bombyx mori,Silkmoths,Silkworms,Silkmoth,Silkworm,Bombyx morus,Bombyxs,mori, Bombyx
D047011 Silk A continuous protein fiber consisting primarily of FIBROINS. It is synthesized by a variety of INSECTS and ARACHNIDS.
D065089 Glycoside Hydrolase Inhibitors Compounds that inhibit or block the activity of GLYCOSIDE HYDROLASES such as ALPHA-AMYLASES and ALPHA-GLUCOSIDASES. alpha-Glucosidase Inhibitor,alpha-Glucosidase Inhibitors,Intestinal alpha-Amylase Inhibitors,Pancreatic alpha-Amylase Inhibitors,alpha-Amylase Inhibitors, Pancreatic,Hydrolase Inhibitors, Glycoside,Inhibitor, alpha-Glucosidase,Inhibitors, Glycoside Hydrolase,Inhibitors, Intestinal alpha-Amylase,Inhibitors, Pancreatic alpha-Amylase,Inhibitors, alpha-Glucosidase,Intestinal alpha Amylase Inhibitors,Pancreatic alpha Amylase Inhibitors,alpha Amylase Inhibitors, Pancreatic,alpha Glucosidase Inhibitor,alpha Glucosidase Inhibitors,alpha-Amylase Inhibitors, Intestinal

Related Publications

Hyun Jung Lee, and Hyun-Sun Lee, and Jang Won Choi, and Kyung Soo Ra, and Jin-Man Kim, and Hyung Joo Suh
March 2016, Chinese journal of natural medicines,
Hyun Jung Lee, and Hyun-Sun Lee, and Jang Won Choi, and Kyung Soo Ra, and Jin-Man Kim, and Hyung Joo Suh
January 2021, Molecules (Basel, Switzerland),
Hyun Jung Lee, and Hyun-Sun Lee, and Jang Won Choi, and Kyung Soo Ra, and Jin-Man Kim, and Hyung Joo Suh
March 2020, Journal of Asian natural products research,
Hyun Jung Lee, and Hyun-Sun Lee, and Jang Won Choi, and Kyung Soo Ra, and Jin-Man Kim, and Hyung Joo Suh
August 2013, International journal of biological macromolecules,
Hyun Jung Lee, and Hyun-Sun Lee, and Jang Won Choi, and Kyung Soo Ra, and Jin-Man Kim, and Hyung Joo Suh
March 2023, Food chemistry,
Hyun Jung Lee, and Hyun-Sun Lee, and Jang Won Choi, and Kyung Soo Ra, and Jin-Man Kim, and Hyung Joo Suh
April 2014, Planta medica,
Hyun Jung Lee, and Hyun-Sun Lee, and Jang Won Choi, and Kyung Soo Ra, and Jin-Man Kim, and Hyung Joo Suh
April 2022, Phytochemistry,
Hyun Jung Lee, and Hyun-Sun Lee, and Jang Won Choi, and Kyung Soo Ra, and Jin-Man Kim, and Hyung Joo Suh
March 2023, Fitoterapia,
Hyun Jung Lee, and Hyun-Sun Lee, and Jang Won Choi, and Kyung Soo Ra, and Jin-Man Kim, and Hyung Joo Suh
October 2016, Journal of natural medicines,
Hyun Jung Lee, and Hyun-Sun Lee, and Jang Won Choi, and Kyung Soo Ra, and Jin-Man Kim, and Hyung Joo Suh
December 2022, Natural product research,
Copied contents to your clipboard!